NCT05514743

Response of Cardiovascular Parameters to Physical Therapy Post Liver Transplantation

Completed NA Last updated 24 August 2022

What this trial tests

NA trial testing 6 minute walk test , Blood pressure monitoring in Liver Transplant; Complications in 30 participants. Completed in 1 April 2022.

Timeline

17 April 2019

Primary endpoint
30 March 2022

1 April 2022

Quick facts

Lead sponsor	General Committee of Teaching Hospitals and Institutes, Egypt
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	single group
Masking	double
Primary purpose	supportive care
Enrollment	30
Start date	17 April 2019
Primary completion	30 March 2022
Estimated completion	1 April 2022
Sites	1 location across Egypt

Drugs / interventions tested

• 6 minute walk test , Blood pressure monitoring

Conditions studied

• Liver Transplant; Complications — all drugs for Liver Transplant; Complications →

Sponsor

General Committee of Teaching Hospitals and Institutes, Egypt

Who can join

Adults 40 to 60, male only, with Liver Transplant; Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Liver transplantation (LT) is the only life-saving treatment option in patients with advanced liver disease. Deceased-donor LT is not frequent but is increasing in Asian countries. Because current liver allocation policies follow the severity principle wherein patients at highest risk for mortality receive top priority, anesthesiologists may face severely ill patients more frequently with deceased-donor LT than with living-donor LT. In this regard, with the outstanding surgical success of recent LT, cardiovascular complications have emerged as the leading cause of death after LT, particularly among those with advanced liver cirrhosis

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.